LOADING
Comparing AbbVie Inc (ABBV) and Merck & Company (MRK), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | MRK |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $464.4B | $356.0B |
| P/E Ratio | 73.6 | 116.4 |
| Forward P/E | 16.4 | 15.3 |
| PEG Ratio | 0.54 | 2.71 |
| EPS | $3.57 | $1.24 |
| Revenue Growth (YoY) | 10.2% | 5.1% |
| Profit Margin | 9.8% | 4.8% |
| Return on Equity | 62.3% | 7.0% |
| Dividend Yield | 2.63% | 2.31% |
| Beta | 0.28 | 0.23 |
| 52-Week High | $269.39 | $156.00 |
| 52-Week Low | $189.40 | $79.67 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. AbbVie Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. AbbVie Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.